Tango Therapeutics Inc.
TNGX | NASDAQ
$24.04
+$1.71 (+7.66%)
Sep 22, 2026, 11:03 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -55.34M | -45.51M | -38.75M | 15.88M | -38.85M | -39.88M | -37.67M | -29.17M | -25.55M | -37.91M | -30.76M | -22.26M | -20.71M | -28.01M | -29.06M | -29.05M | -24.86M | -25.21M | -22.05M | -19.59M | -4.49M | -12.11M |
Depreciation & Amortization | 425K | 463K | 479K | 555K | 625K | 622K | 620K | 622K | 632K | 625K | 617K | 613K | 604K | 581K | 570K | 417K | 312K | 309K | 256K | 225K | 212K | 204K |
Stock-Based Compensation | 16.89M | 10.8M | 5.98M | 6.63M | 6.57M | 7.26M | 7.46M | 7.18M | 7.54M | 6.72M | 4.88M | 4.86M | 5.12M | 4.22M | 3.79M | 3.82M | 3.43M | 3.21M | 2.26M | 3.43M | 1.2M | 950K |
Other Working Capital | -107K | -11.83M | 3.63M | -54.08M | -4.28M | -11.65M | -4.64M | -14.83M | -3.22M | -7.87M | -662K | -14.06M | -8.3M | -15.24M | -2.94M | 130K | -8.76M | -8.03M | -4.14M | -3.99M | -4.94M | -5.52M |
Other Non-Cash Items | 24K | -63K | 171K | 412K | 295K | 318K | 88K | -245K | -236K | -456K | -1.45M | 1.67M | 24K | -12K | 417K | 584K | 335K | 415K | 404K | 309K | 310K | 300K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -866K | -10.04M | 2.4M | -54.43M | -5.16M | -10.02M | -7.15M | -11.78M | -5.99M | -6.83M | -750K | -16.02M | -9.51M | -11.69M | -3.98M | 4.62M | -10.75M | -8.39M | 2.23M | -5.87M | -4.74M | -2.96M |
Operating Cash Flow | -38.87M | -44.36M | -29.72M | -30.95M | -36.52M | -41.7M | -36.65M | -33.39M | -23.61M | -37.86M | -27.47M | -31.14M | -24.47M | -34.91M | -28.27M | -19.61M | -31.54M | -29.67M | -16.9M | -21.49M | -7.52M | -13.61M |
Capital Expenditures | n/a | n/a | -222K | -151K | -624K | -51K | -124K | -115K | -320K | -195K | -226K | -16K | -664K | -620K | -1.04M | -3.28M | -1.81M | -1.56M | -696K | -774K | -202K | -165K |
Cash Acquisitions | 20K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -519.1M | -54.41M | -175.02M | -18.34M | -23.94M | -47.16M | -32.55M | -39.47M | -48.61M | -120.26M | -51.03M | -156.24M | -50.78M | -52.53M | -93.56M | -44.46M | -15.92M | -54.57M | -104.39M | -181.86M | -66.25M | -19.87M |
Sales Maturities Of Investments | 73.1M | 64.05M | 39.53M | 65.97M | 41.34M | 77.81M | 84.73M | 72.15M | 61.63M | 109.26M | 85.1M | 99.59M | 84.13M | 84.71M | 81.99M | 62.96M | 53.23M | 44.42M | 59.87M | 30.42M | 59.83M | 40.65M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -445.97M | 9.64M | -135.72M | 47.48M | 16.78M | 30.6M | 52.06M | 32.57M | 12.7M | -11.2M | 33.85M | -56.66M | 32.69M | 31.55M | -12.61M | 15.23M | 35.49M | -11.72M | -45.21M | -152.21M | -6.63M | 20.61M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -95K | -537K | -36K | n/a | n/a | 2K | 969K | 2.4M | 1.31M | 1.26M | 1.47M | 441K | 586K | 73K | 527K | 113K | 718K | 257K | -120K | 327.78M | -738K | 413K |
Financial Cash Flow | 672.57M | 79.85M | 219.38M | 2.54M | 581K | 2K | 969K | 2.4M | 1.31M | 42.98M | 1.47M | 80.28M | 586K | 73K | 527K | 113K | 718K | 257K | -120K | 327.78M | -746K | 30.41M |
Net Cash Flow | 187.73M | 45.12M | 53.94M | 19.07M | -19.16M | -11.1M | 16.38M | 1.58M | -9.6M | -6.08M | 7.85M | -7.52M | 8.8M | -3.28M | -40.34M | -4.27M | 4.67M | -41.13M | -62.23M | 154.07M | -14.89M | 37.41M |
Free Cash Flow | -38.87M | -44.36M | -29.94M | -31.1M | -37.14M | -41.75M | -36.77M | -33.51M | -23.93M | -38.05M | -27.69M | -31.15M | -25.14M | -35.53M | -29.31M | -22.89M | -33.35M | -31.23M | -17.6M | -22.27M | -7.72M | -13.78M |
Adj. Free Cash Flow | -55.76M | -55.16M | -35.92M | -37.73M | -43.71M | -49M | -44.23M | -40.68M | -31.47M | -44.77M | -32.57M | -36.01M | -30.26M | -39.75M | -33.09M | -26.71M | -36.77M | -34.43M | -19.86M | -25.7M | -8.92M | -14.73M |
Maintenance CapEx | n/a | n/a | -222K | n/a | -624K | -51K | -124K | n/a | n/a | n/a | -226K | n/a | n/a | -611.41K | -399.26K | -3.16M | -1.81M | -1.56M | -696K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | -151K | n/a | n/a | n/a | -115K | -320K | -195K | n/a | -16K | -664K | -8.59K | -641.74K | -122.81K | n/a | n/a | n/a | -774K | -202K | -165K |
Owner Earnings | -38.87M | -44.36M | -29.94M | -30.95M | -37.14M | -41.75M | -36.77M | -33.39M | -23.61M | -37.86M | -27.69M | -31.14M | -24.47M | -35.52M | -28.67M | -22.77M | -33.35M | -31.23M | -17.6M | -21.49M | -7.52M | -13.61M |
Add to Watchlist
Select watchlists to add or remove TNGX